Stock NERV MINERVA NEUROSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Minerva Neurosciences, Inc.

Equities

NERV

US6033802058

Delayed Nasdaq
Other stock markets
 03:27:11 2024-05-02 pm EDT 		5-day change 1st Jan Change
2.406 USD +0.26% Intraday chart for Minerva Neurosciences, Inc. -0.98% -60.87%
May. 01 Minerva Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 27 Sector Update: Health Care Stocks Ease Late Afternoon MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Minerva Neurosciences: Q1 Earnings Snapshot
AQ
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
AQ
Minerva Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Sector Update: Health Care Stocks Ease Late Afternoon
MT
Top Midday Decliners
MT
Sector Update: Health Care Stocks Decline Tuesday Afternoon
MT
Minerva Neurosciences Shares Tumble After FDA Rejects Roluperidone for Schizophrenia.
MT
Minerva Neurosciences Shares Slide on Latest FDA Roluperidone Setback
DJ
FDA Turns Away Minerva's Roluperidone Schizophrenia Drug
DJ
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
CI
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
AQ
Minerva Neurosciences: Q4 Earnings Snapshot
AQ
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
AQ
Minerva Neurosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Minerva Neurosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Minerva Neurosciences: Q3 Earnings Snapshot
AQ
Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
AQ
Minerva Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Minerva Neurosciences : Aug 15, 2023
PU
HC Wainwright Adjusts Price Target on Minerva Neurosciences to $11 From $8, Maintains Neutral Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NERV Stock
  4. News Minerva Neurosciences, Inc.